- 英文名称
- Elinzanetant
- 分子式
- C33H35F7N4O3
- 分子量
- 668.64
- 中文别名
- 2-(3,5-双(三氟甲基)苯基)-N-(4-(4-氟-2-甲基苯基)-6-((7S,9aS)-7-(羟甲基)六氢吡嗪并[2,1-c][1,4]恶嗪-8(1H)-基)吡啶-3-基)-N,2-二甲基丙酰胺; 依林唑坦; GSK1144814A; NT-814; NT 814; NT814; GSK-1144814A; GSK 1144814A; N-[4-(4-氟-2-甲基苯基)-6-[(7S,9aS)-六氢-7-(羟基甲基)吡嗪并[2,1-c][1,4]恶嗪-8(1H)-基]-3-吡啶基]-N,α,α-三甲基-3,5-双(三氟甲基)苯乙酰胺; 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethylpropanamide; 2-[3,5-Bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide; N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide; Benzeneacetamide, N-[4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-hexahydro-7-(hydroxymethyl)pyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl]-N,α,α-trimethyl-3,5-bis(trifluoromethyl)-; BAY3427080; BAY-3427080; BAY 3427080
- 用途
- 化学合成；作为具有口服活性的选择性NK-1,3受体拮抗剂，用于血管舒缩和精神分裂症研究
